白云山预计2025年度日常关联交易总额超8亿元

财中社
29 Nov 2024

  财中社11月29日电白云山(600332/00874)发布关于2025年度日常关联交易预计的公告。公司及其附属企业2025年度预计与广州白云山和记黄埔中药有限公司(“白云山和黄”)、广州百特侨光医疗用品有限公司(“百特侨光”)及广州白云山一心堂医药投资发展有限公司(“白云山一心堂”)及其附属企业之间发生的日常关联交易金额分别不超过4.38亿元、2.21亿元及1.88亿元。此次日常关联交易无需提交股东大会审议,且不对关联方形成较大依赖,有利于公司业务的持续发展。

  2024年前三季度,白云山实现收入590.60亿元,归母净利润31.59亿元。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10